Medication info
Hypertelmival 40 mg (Telmisartan)

Hypertelmival 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Korea Hutech Pharmaceutical Co., Ltd.
Appearance
White or almost white, double-convex round tablets
Packaging
30 tablets/blister [10 tablets/blister X 3]
Approval status
Active

MFDS item code 201500978 · Approved 2015.02.25 · Insurance code 649102640

Summary

Main use
Treatment of essential hypertension, prevention of cardiovascular diseases (such as myocardial infarction and stroke)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is reached 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Korea Hutech Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, prevention of cardiovascular diseases (such as myocardial infarction and stroke)

  • Essential hypertension
View approved original text

This medication helps to control blood pressure in patients with essential hypertension and improve cardiovascular health. Additionally, in cases where ACE inhibitors cannot be used, it is effective in reducing the risk of myocardial infarction, stroke, and death due to cardiovascular disease in patients aged 55 and older with a high risk of cardiovascular disease. It is particularly useful in high-risk patients with coronary artery disease, peripheral artery disease, stroke, or diabetes. This drug may help prevent serious complications related to cardiovascular diseases. Therefore, it is actively used for hypertension management and reduction of cardiovascular disease risk.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is reached 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water and may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm or risk of death to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergic reactions, severely impaired liver function, pregnant or breastfeeding women, or patients with certain kidney diseases. Elderly patients or those with reduced kidney function, as well as patients with heart or vascular problems, should use this medication with caution and monitor their condition closely. Upon taking this medication, blood pressure may drop too low, or dizziness, fainting, etc. may occur, so if these symptoms appear, immediate consultation with medical staff is necessary. There is a risk of increased potassium levels in the blood, so patients at risk of hyperkalemia should have regular blood tests for monitoring. It can affect liver or kidney function, so periodic liver and kidney function tests are important during treatment. This medication may interact with other antihypertensives, diuretics, lithium, non-steroidal anti-inflammatory drugs (NSAIDs), etc., so it is crucial to inform your healthcare provider if you are taking other medications. Caution is needed when driving or operating hazardous machinery due to the risk of dizziness or fainting. This medication contains sorbitol, so individuals with fructose intolerance should avoid it. Pregnant women or those planning to become pregnant should not use this medication, and it is also recommended that breastfeeding women avoid it. Children under 18 years of age should not use this medication, as its safety and efficacy have not been established. In case of overdose, there is a risk of hypotension, dizziness, acute renal failure, etc., and immediate contact with medical personnel for appropriate treatment is necessary. This medication should be stored out of reach of children, and the package should not be opened until just before taking it.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 121 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • fainting
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • indigestion
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • dysgeusia
  • abnormal liver function
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic epidermal necrolysis
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute kidney failure
  • chest pain
  • weakness
  • influenza-like illness
  • elevated serum creatinine
  • elevated serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • malaise
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • angioedema
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • interstitial pneumonia
  • fever
  • abnormal chest X-ray
  • rhabdomyolysis
  • myalgia
  • elevated creatine kinase
  • increased serum and urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • headache
  • dizziness
  • cough
  • indigestion
  • arrhythmia
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • facial swelling
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • indigestion
  • cough
  • abdominal pain
  • loss of appetite
  • weakness
  • intestinal vasculitis
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • hypotension
  • tachycardia
  • bradycardia
  • dizziness
  • acute kidney failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering and kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain its effectiveness.

Appearance and packaging

Appearance

White or almost white, double-convex round tablets

Package unit

30 tablets/blister [10 tablets/blister X 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.